The 12 closest competitors and alternatives to Vella Bioscience, Inc. among biotechnology companies — ranked by similarity to what Vella Bioscience, Inc. actually does, not by market-cap band.
Subscribe to see Vella Bioscience, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Vella Bioscience, Inc. is a United States-based company specializing in women's intimate care, arousal, and wellness products. Its offerings are designed to enhance arousal, comfort, and hormonal balance.
Vella Bioscience, Inc. is a biotechnology company headquartered in United States. Its most recent funding round, Seed II, raised $4M in July 2026. Xcout tracks 1 named person at Vella Bioscience, Inc., including Harin Padma-Nathan (Chief Medical Officer).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed II | $4M | 1 named | |
| Seed | $7M | 2 named | |
| SEC Form D filing | $1.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Vella Bioscience, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive. Additionally, the company is actively advancing EVO100, an antimicrobial vaginal gel under development, intended to prevent the urogenital spread of both Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. The company's main office is situated in San Diego, California.
Biotech
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation of lopinavir and ritonavir in a soft gel vaginal insert to treat genital human papillomavirus (HPV) infection, cervical intraepithelial neoplasia, and other HPV-related pathologies. In addition, the company develops DARE-PDM1, a hydrogel formulation of diclofenac for vaginal administration to treat primary dysmenorrhea; DARE-204 and DARE-214, injectable formulations of etonogestrel that provides contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. Further, it develops DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design controlled contraceptive option; DARE-RH1, an approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein; DARE-LBT, a vaginal thermosetting gel formulation for the delivery of live biotherapeutics; and DARE-GML, which delivers antimicrobial glycerol monolaurate intravaginally. Daré Bioscience, Inc. was founded in 2015 and is headquartered in San Diego, California.
Similar biotechnology company
MenoGeniX, Inc. is a pharmaceutical and healthcare company headquartered in Colorado, United States. The company focuses on the development of therapeutic products targeting women's health.
Biotech
Zero Candida Technologies, Inc. is a publicly traded FemTech company that designs, develops, manufactures, and sells non-drug blue light therapy devices for women's health. The company is developing an AI-driven, smart tampon-like medical device utilizing a therapeutic light source to address unmet needs in gynecology.
Similar biotechnology company
Oriva Therapeutics is a biotechnology and pharmaceutical company headquartered in Barcelona, Spain. The venture is dedicated to advancing innovative and disease-modifying approaches to improve clinical outcomes for chronic women's health conditions.
Healthcare & Biotechnology
Hera Diagnostics Corp develops non-invasive, AI-powered diagnostic tools and molecular tests for women's health conditions, focusing on endometriosis detection and staging as well as point-of-care cervical cancer screening. The company provides practice-ready diagnostic solutions for OB-GYN, fertility, and clinical care workflows.
Consumer Healthcare
FemmePharma Consumer Healthcare develops and sells health and wellness products designed for women experiencing perimenopause and menopause. Their product lineup includes personal lubricants, moisturizers, and dietary supplements that target symptoms such as vaginal dryness, hot flashes, and sleep disturbances.
Healthtech
O Positiv, Inc. is a wellness and health company based in California that specializes in women's health and hormone support products.
Healthtech
Bellabeat, Inc. is a high-tech wellness company that designs and develops smart health trackers and connected wearable devices tailored for women's health monitoring.
Health & Wellness Supplements
Purefemm is an e-commerce company that offers dietary supplements and wellness products specifically formulated for women's health.
Healthcare
Materna Medical Inc. is a women's health innovation company headquartered in Mountain View, California, focused on developing solutions for pelvic health, including the Ellora product.
Pharma, Women's Health
Pharmiva AB is a Swedish women’s-health company that develops and commercializes non-hormonal vaginal-health products. Its best-known product is VagiVital, intended to treat symptoms such as vaginal dryness and discomfort, serving women with vaginal health needs.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Vella Bioscience, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →